Epsilon M&A Deal Report - Lusomedicamenta-sociedade Tecnica Farmaceutica
Transaction Multiples for the Valuation of Private Companies
Recipharm / Lusomedicamenta-sociedade Tecnica Farmaceutica
No EMAT :
68626
Announced Date :
14/11/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Recipharm
Target :
Lusomedicamenta-sociedade Tecnica Farmaceutica
Country :
Portugal
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Established in 2004, Lusomedicamenta is primarily a CDMO specialised in the development and manufacture of solid, liquid and semi-solid dose forms as well as sterile ophthalmic products . > Operates...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | |||||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 06/10/2014 | Private Group led by Qualium Investissement | Aigle Capital (IMV Technologies) | France | ** | 68494 |
| 13/12/2014 | Private Group Led by Emerald Investment Partners | Carechoice | Ireland | * | 68314 |
Source: Epsilon Research / EMAT
